PrimeGen US Enters Definitive Business Combination With DT Cloud Star Acquisition Corporation

DAS Health Acquires Prime Care Technologies and Prime Cloud from Prime Holdings

April 9, 2026

IT Services

DAS Health announced it has acquired Prime Care Technologies and Prime Cloud, both divisions of Prime Holdings. The deal expands DAS Health’s national footprint and strengthens its managed IT, cybersecurity, and professional services offerings purpose-built for senior living and long-term care operators.

Swiss Rockets AG to Acquire Complete Genomics

February 23, 2026

Healthcare Services

Complete Genomics entered into a definitive agreement to be acquired by Swiss Rockets AG, subject to customary closing conditions and approval by MGI shareholders. Swiss Rockets will own 100% of Complete Genomics and have sole control, while Complete Genomics continues operating as a U.S.-based company with its management team retaining responsibility for day-to-day operations and customer relationships.

Vizgen Acquires Ultivue (Merger to Form Combined Spatial Biology Company)

October 9, 2024

Biotechnology

Vizgen and Ultivue have merged to create a single spatial biology company that combines Vizgen’s MERFISH single-cell spatial genomics platform with Ultivue’s InSituPlex assays and STARVUE proteomic/AI capabilities. Rob Carson (former CEO of Ultivue) will serve as President and CEO of the combined Vizgen, and the transaction was completed alongside Vizgen’s Series D financing backed by investors including ARCH Venture Partners, Northpond Ventures and Tao Capital Partners.

Genstar Capital Makes Strategic Majority Investment in Docupace

July 23, 2024

Cloud & SaaS

Genstar Capital has made a strategic majority investment in Docupace, a Holmdel, New Jersey-based provider of cloud-based software for wealth management back-office operations. The transaction is a recapitalization that will leave FTV Capital as a minority investor and position Docupace to accelerate organic and inorganic growth of its platform.

Genexine Announces Merger with EPD Biotherapeutics (EPD Bio)

July 4, 2024

Biotechnology

Genexine, a clinical-stage Korean biopharmaceutical company, announced a small-scale merger with EPD Biotherapeutics (EPD Bio) to strengthen its drug development pipeline. The merger is intended to add PROTAC/bioPROTAC (bioPROTAC via EPDegTM mRNA-LNP) technology talent and expand Genexine’s R&D capabilities, with EPD Bio’s founder joining Genexine to lead R&D.

ProPhase Labs Acquires Nebula Genomics

August 11, 2021

Biotechnology

ProPhase Labs, through its newly formed subsidiary ProPhase Precision Medicine, completed the acquisition of Nebula Genomics, a privately owned whole‑genome sequencing and personal genomics company. The deal (approximately $14.6 million in a mix of cash and ProPhase common stock) will integrate Nebula’s whole genome sequencing capabilities and DTC platform into ProPhase’s CLIA-certified molecular testing laboratories to expand diagnostic and consumer genomics offerings.